SCF型泛素连接酶E3作为癌症的靶标

Title:The SCF-type E3 Ubiquitin Ligases as Cancer Targets

Volume: 16 Issue: 2

Author(s): Kyoko Kitagawa and Masatoshi Kitagawa

Affiliation:

关键词: β- -TrCP 泛素连接酶，E3连接酶，F-box蛋白，抑癌基因FBXW7，人类癌症，蛋白酶体，SCF复合体，S期激酶相关蛋白Skp2，泛素

摘要: The ubiquitin system controls protein stability and function. F-box proteins form SCF (SKP1-Cullin1-F-box protein)-type ubiquitin (E3) ligases to selectively target their substrates for degradation via the ubiquitin–proteasome pathway. Here, we review F-box proteins associated with cancer development. S-phase kinase-associated protein 2 (SKP2) (also known as FBXL1) is often overexpressed in human cancers, and functions as an oncogenic E3 ligase to degrade tumor suppressor gene products. Moreover, F-box/WD repeat-containing protein 7 (FBXW7) (also known as Fbw7) is often mutated in human cancers and functions as a tumor suppressive E3 ligase targeting oncogenic proteins for degradation. SKP2 is a potential drug target for cancer therapy and FBXW7 is useful in determining patient diagnosis, prognosis, and drug sensitivity. In this review, we also discuss other F-box proteins involved in cancer-associated cellular processes such as cell cycle control, epigenetic regulation, epithelial mesenchymal transition, apoptosis/survival, drug resistance, and DNA-damage responses.

Cite this article as:

Kyoko Kitagawa and Masatoshi Kitagawa , The SCF-type E3 Ubiquitin Ligases as Cancer Targets, Current Cancer Drug Targets 2016; 16 (2) . https://dx.doi.org/10.2174/1568009616666151112122231